Summary

China CGM Devices Market Size & Trends

The China continuous glucose monitoring devices market size was estimated at USD 231.4 million in 2024 and is projected to grow at a CAGR of 19.4% from 2025 to 2033 to reach a value of USD 1,142.1 million in 2033. The China continuous glucose monitoring (CGM) devices industry is expanding due to the sharp rise in diabetes cases, driven by urbanization, sedentary habits, and dietary shifts. A 2023 study shows 233 million diabetic patients in China is up 163% since 2005, with prevalence rising from 7.53% to 13.7%.

This growing burden, along with enhanced public health awareness, improved healthcare infrastructure, and government support for advanced monitoring tools, is fueling CGM adoption. Integration with smartphones and wearables adds to user convenience. Manufacturers are investing in cost-effective innovations, and the rising demand for real-time glucose tracking is further boosting market growth across healthcare settings.

Initially developed for managing type 1 and type 2 diabetes, CGMs have gained widespread popularity beyond traditional use, particularly among young individuals seeking better lifestyle and health monitoring. Videos tagged “sugar control” on Douyin, China’s version of TikTok, have garnered over 20.8 billion vie, indicating massive interest. The wearable nature and real-time tracking capabilities of CGM devices have made them appealing to younger, tech-savvy users. Users now rely on CGMs for weight management and dietary planning, illustrating the market's shift toward preventive health behaviors.

According to Sinocare’s Director of CGM Consumer Business for China, sales of CGM needles surged by 63% year-on-year in H2 2024, while Sinocare’s sales doubled, growing by 104% on major platforms like T-mall and JD.com. This reflects both growing public interest and market penetration, especially among youth newly diagnosed or at risk for diabetes. Expert voices add credibility to this trend.

China Continuous Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the China continuous glucose monitoring devices market report based on product, connectivity, indication and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Standalone CGM Devices
o Devices
o Consumables (Receivers, Sensors, and Transmitters)
• Integrated CGM-Insulin Pump Systems
• Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
• Bluetooth
• 4G/Cellular
• NFC (Near Field Communication)
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Type 1 Diabetes
• Type 2 Diabetes
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmacies
• E-commerce
• Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. China CGM Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. China CGM Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. China CGM Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. China Continuous Glucose Monitoring Devices Market Product Movement Analysis
4.3. China Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2024 to 2033 (USD Million)
4.4. Standalone CGM Devices
4.4.1. Standalone CGM Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.1. Devices
4.4.1.1.1. Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2. Consumables
4.4.1.2.1. Consumables (Receivers, Sensors, and Transmitters) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Integrated CGM-Insulin Pump Systems
4.5.1. Integrated CGM-Insulin Pump Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. China CGM Devices Market: Connectivity Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. China Continuous Glucose Monitoring Devices Market Connectivity Movement Analysis
5.3. China Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Connectivity, 2025 to 2033 (USD Million)
5.4. Bluetooth
5.4.1. Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. 4G/Cellular
5.5.1. 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. NFC (Near Field Communication)
5.6.1. NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. China CGM Devices Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. China Continuous Glucose Monitoring Devices Market Indication Movement Analysis
6.3. China Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Indication, 2025 to 2033 (USD Million)
6.4. Type 1 Diabetes
6.4.1. Type 1 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Type 2 Diabetes
6.5.1. Type 2 Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. China CGM Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. China Continuous Glucose Monitoring Devices Market End Use Movement Analysis
7.3. China Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by End Use, 2025 to 2033 (USD Million)
7.4. Pharmacies
7.4.1. Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. E-commerce
7.5.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Abbott
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Dexcom
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Sinocare Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Medtronic plc
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Ascensia Diabetes Care
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Trinity Biotech
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. MicroTech Medical
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Meiqi Medical
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Yuwell
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. i-SENS Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives